The role of eosinophil cationic protein in patients with Mycoplasma pneumoniae infection

Journal of the Chinese Medical Association

Volumn 71, Issue 1, 2008, Pages 37-39

  Chen, Chun Jen ^a,b   Hung, Miao Chiu ^a,b   Kuo, Kai Liang ^a,b   Chung, Jui Lung ^a,b   Wu, Keh Gong ^a,b   Hwang, Be Tau ^a,b   Tang, Ren Bin ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Asthma; Eosinophil cationic protein; Mycoplasma pneumoniae; Pneumonia

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; RNASE3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ASTHMA; BACTERIAL INFECTION; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOASSAY; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INJURY; STATISTICAL SIGNIFICANCE; BLOOD; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ASTHMA; CHILD; CHILD, PRESCHOOL; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; MALE; PNEUMONIA, MYCOPLASMA;

EID: 41649105327     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70070-4     Document Type: Article

References (12)

1. Frick OL. Effect of respiratory and other virus infection on IgE immunoregulation. J Allergy Clin Immun 1986;78:1013-8.
2. Grayston JT, Alexander ER, Kenny GE, Clarke ER, Fremont JC, MacColl WA. Mycoplasma pneumoniae infections: clinical and epidemiologic studies. JAMA 1965;191:369-74.
3. Glezen WP, Thornburg G, Chin TDY, Wenner HA. Significance of mycoplasma infections in children with respiratory disease. Pediatrics 1967;39:516-25.
4. Fernald GW, Collier AM, Clyde WA. Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics 1975;55:327-35.
5. Rastawicki W, Raty R, Kleemola M. Detection of antibodies to Mycoplasma pneumoniae adhesion P1 in serum specimens from infected and non-infected subjects by immunoblotting. Diagn Micrl Infec Dis 1996;26:141-3.
6. Rastawicki W. Evaluation of the usefulness of using Western immunoblotting for testing Immoral immune response to Mycoplasma pneumoniae antigens during natural infection in humans. Med Dosw Mikrobiol 1996;48:39-48.
7. Kitahara H, Yamashita R, Kanemitsu T, Niwa I, Osano M. Relationship between M. pneumoniae infections and eosinophilia. Proceedings of the 12th Annual Congress of the Japanese Society of Mycoplasmology 1985:75-8.
8. Yamashita I, Kitahara H, Kanemitsu T, Takeda T, Yamaguchi S. Eosinophil cationic protein in the sera of patients with Mycoplasma pneumonia. Pediatr Infect Dis J 1994;13:379-81.
9. NIH/WHO. Global Strategy for Asthma Management and Prevention: Updated Workshop Report. Bethesda: National Institutes of Health, 2005.
10. Kim HH, Lee MH, Lee SL. Eosinophil cationic protein and chemokines in nasopharyngeal secretions of infants with respiratory syncytial virus (RSV) bronchiolitis and non-RSV bronchiolitis. J Korean Med Sci 2007;22:37-42.
11. Gleich GJ, Loegering DA, Bell MP, Checkel JL, Ackerman SJ, McKean DJ. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci USA 1981;83:3146-50.
12. Morojima S, Frigas E, Loegering DA, Gleich GJ. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 1989;139:801-5.